The Liver as an Endocrine Organ—Linking NAFLD and Insulin Resistance

Tissue-based map of the human proteome

Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760

The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896

Mammalian microRNAs predominantly act to decrease target mRNA levels

Guo, H., Ingolia, N. T., Weissman, J. S., & Bartel, D. P. (2010) · Nature · doi:10.1038/nature09267 · Cited by 3,886

Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes

Trajković, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., Schwille, P., Brügger, B., & Simons, M. (2008) · Science · doi:10.1126/science.1153124 · Cited by 3,760

TLR4 links innate immunity and fatty acid-induced insulin resistance

Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690

Coordinated liver-serum-adipose lipid alterations and hepatic proteins regulate tissue-specific deposition of intramuscular and abdominal fat in chickens

Lin, Z., Yang, C., Tang, Y., Wang, Y., Yu, S., Zhang, D., Yu, C., & Liu, Y. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107209 · Cited by 1

Liquiritin restores metabolic homeostasis in NAFLD by modulating AKT1/FOXO1 signaling

Zhang, Z., Jiao, S., Jiang, T., Zhang, R., Sun, Z., Zhang, Z., Pan, Y., & Guo, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1809617 · Cited by 1

Liquiritigenin ameliorates adipocyte insulin resistance by inhibiting pro-inflammatory polarization of macrophages via regulation of the mtROS/OXPHOS axis

Lv, C., Tan, J., Ouyang, H., Zhang, Z., Liu, X. W., & Zheng, W. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158509 · Cited by 1

Exercise-conditioned extracellular vesicles in Alzheimer’s disease: a multi-organ signaling network linking peripheral adaptation to brain pathology

Zhang, R. X., & Chen, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1856546 · Cited by 1

Heart–liver co-management in MASLD: expert perspectives and recommendations from a multidisciplinary cardiometabolic framework

Zhou, X., Jeong, S., Chen, Q., Targher, G., Byrne, C. D., Chew, N. W., Younossi, Z. M., Lip, G. Y. H., Tilg, H., George, J., et al. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01255-z · Cited by 3

Correlation of Hepatic Steatosis Among Cohabitants Using Hounsfield Unit From Coronary Computed Tomography

Ali, Z., Saeed, I. M., Bybee, K. A., Thompson, R. C., O’Keefe, J. H., Shafiq, M., Saeed, L., Zafar, Y., Kennedy, K., & Al‐Sayyed, L. (2021) · Cureus · doi:10.7759/cureus.17834 · Cited by 1

Metabolic dysfunction-associated fatty liver disease from definition to complications

Ezzat, A. A., & Elmoghazy, M. (2021) · Medical Journal of Viral Hepatitis /Medical Journal of Viral Hepatitis · doi:10.21608/mjvh.2021.211705 · Cited by 1

Neck circumference – a marker of insulin resistance in the normal-weight Polish [pdf]

Pastusiak, K., Michałowska, J. M., Seraszek‐Jaros, A., & Bogdański, P. (2022) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.2022.1021 · Cited by 1

Insulino-resistenza e fertilità nella donna con attenzione a sindrome dell’ovaio policistico (PCOS) e malattia epatica non alcoolica (NAFLD)

Stasi, V. D., Cipriani, S., Maseroli, E., Scavello, I., & Vignozzi, L. (2022) · L Endocrinologo · doi:10.1007/s40619-022-01037-0 · Cited by 1

Development of an in vitro insulin resistance dissociated model of hepatic steatosis by co-culture system

Xiao, J., Li, X., Zhou, Z., Guan, S., Zhuo, L., & Gao, B. (2022) · BioScience Trends · doi:10.5582/bst.2022.01242 · Cited by 1

Circulating leukocyte cell-derived chemotaxin 2 and fibroblast growth factor 21 are negatively associated with cardiorespiratory fitness in healthy volunteers

Malaikah, S., Willis, S. A., Henson, J. J., Sargeant, J. A., Yates, T. E., Thackray, A. E., Goltz, F. R., Roberts, M. J., Bernard-Deshong, D., Aithal, G. P., et al. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2022-0445 · Cited by 1

Manifestations of Liver Impairment and the Effects of MH-76, a Non-Quinazoline α1-Adrenoceptor Antagonist, and Prazosin on Liver Tissue in Fructose-Induced Metabolic Syndrome

Kubacka, M., Nowak, B., Zadrożna, M., Szafarz, M., Latacz, G., Marona, H., Sapa, J., Mogilski, S., Bednarski, M., & Kotańska, M. (2023) · Metabolites · doi:10.3390/metabo13111130 · Cited by 1

Obesity-mediated insulin resistance in target tissues: role of adiponectin, fetuin-A, and irisin

Mukherjee, S., Das, S., Chattopadhyay, D., & Mukhopadhyay, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00041-4 · Cited by 2

Hormonal Manifestations of Endocrine Diseases

Singh, J., Kottarath, S. K., Bano, F., Farhan, M., Tripathi, A. K., & Srivastava, Y. (2024) · Springer eBooks · doi:10.1007/978-981-97-4723-8_11 · Cited by 1

Biomarkers of risk and prognosis in atrial fibrillation

Stepanenko, I. A., Mirzoyan, N. A., Ruban, A. V., Sopova, D. I. S., Салухов, В. В., & Tarasov, V. A. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-379 · Cited by 1

High serum EDA concentration is associated with metabolic syndrome and its determinants

Deng, X., Li, Y., Gu, T., Wu, X., Sun, Z., Li, H., Yang, L., & Yuan, G. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02408-9 · Cited by 1

Long-lasting recombinant HEXA treatment improves hepatic steatosis and glycemic control in mild, but not severe, metabolic dysfunction-associated steatohepatitis

Lin, S., Dong, L., Nardo, W. D., Leeming, M. G., Cheng, Z., Williamson, N. A., Watt, M. J., & Montgomery, M. K. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00359.2024 · Cited by 1

Acanthosis Nigricans as a Clinical Risk Marker for Metabolic Dysfunction-Associated Steatotic Liver Disease

Sánchez‐García, A., Penados-Ovalle, M. E., Rodríguez-Gutiérrez, R., González-Colmenero, F. D., & González‐González, J. G. (2025) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514251345047 · Cited by 1

An experimental study to investigate the impact of Aspirin and Vitamin C therapy on fructose induced hepatic and pancreatic damage

Yeşilot, Ş., Özer, M. K., Gültekin, F., Öncü, M., Candan, İ. A., Dağdeviren, B. H., & Çiçek, E. (2022) · Turkish Journal of Health Science and Life · doi:10.56150/tjhsl.1143635 · Cited by 1

Hepatokines as Biomarkers of Obesity-Associated Liver Pathophysiology: Deciphering Advances in Basic and Clinical Aspects

Ishtiaq, S. M. (2023) · Advances in Pharmacology & Clinical Trials · doi:10.23880/apct-16000228 · Cited by 1

The changes of serum fibrinogen-like protein 1 levels associated with improved liver function and uric acid after laparoscopic sleeve gastrectomyPreprint

Qu, S., Dilimulati, D., Du, L., Huang, X., Cai, M., Zhang, Y., Zhou, D., Zhu, J., Su, L., & Zhang, M. (2022) · Research Square · doi:10.21203/rs.3.rs-1311106/v1 · Cited by 1

WITHDRAWN: Dysregulation of miR-129-5p in Patients with Non-Alcoholic Fatty Liver Disease and Its Regulatory Effect on Insulin ResistancePreprint

Zhang, H., Niu, Q., Liang, K., Li, X., Jiang, J., & Bian, C. (2020) · Research Square · doi:10.21203/rs.3.rs-83173/v1 · Cited by 1

Impact of Zinc on Insulin Resistance and Hepatic Fat AccumulationPreprint

Fatehi, M. (2023) · Preprints.org · doi:10.20944/preprints202301.0012.v1 · Cited by 1

Are hepatocytes endocrine cells?

Lu, Y., Zheng, M., & Wang, H. (2023) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.11 · Cited by 1

The determination of the comparative effect of Ertugliflozin, Pioglitazone, and Metformin on patients of non-alcoholic fatty liver disease in type 2 diabetes mellitus.Preprint

Khaliq, A., Badshah, H., Shah, Y., & Rehman, I. U. (2024) · Research Square · doi:10.21203/rs.3.rs-3982234/v1 · Cited by 1

Liver Smn Restoration Rescues the Smn2b/- Mouse Model of Spinal Muscular Atrophy: The Key to Rescue Whole Body Pathology?Preprint

Sutton, E. R., Beauvais, A., Yaworski, R., Repentigny, Y. D., Reilly, A., de Almeida, M. M. A., Deguise, M., Poulin, K. L., Parks, R. J., Schneider, B. L., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4828743 · Cited by 1

Quercetin Ameliorates Fatty Acid Oxidation in the Pathogenesis of NAFLD Based on Network Pharmacology and Molecular DockingPreprint

Zhu, W., Dai, Y., Lin, J., Chen, Y., Rao, X., Wang, J., Zhou, J., & Shen, T. (2021) · Research Square · doi:10.21203/rs.3.rs-223444/v1

Increased Circulating Levels of EDA in Newly Diagnosed Type 2 Diabetic PatientsPreprint

Deng, X., Li, Y., Wu, X., Zhao, L., Li, H., Chen, K., Zhang, P., Zhao, Z., Qiu, Y., Yang, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-189239/v1

The Novel Hepatokine Ectodysplasin A Is Increased in Obesity and Reduced after Liraglutide ManagementPreprint

Cai, Z., Deng, X., Zhang, P., Zhao, Z., Guo, C. Y., Wang, C., Li, L., Li, H., Gu, T., Yang, L., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-508975/v1

Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19

Campos-Murguía, A., Román-Calleja, B. M., González-Regueiro, J. A., de León, I. H.-D., Solís-Ortega, A. A., Flores-García, N. C., García-Juárez, I., Ruiz‐Margáin, A., & Macías‐Rodríguez, R. U. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5502

Association between Serum Uric Acid to HDL-cholesterol Ratio and Nonalcoholic Fatty Liver Disease among Chinese AdultsPreprint

Zhao, H. J., Qiu, X., Cui, J., & Sun, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-1025949/v1

Investigation of the potential mechanism of the Shugan Xiaozhi decoction for the treatment of nonalcoholic fatty liver disease based on network pharmacology and molecular dockingPreprint

Xing, Y., Yang, R., Yang, H., Jiang, D., Xu, L., & Feng, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1294807/v1

Alanine Aminotransferase, Body Mass Index, and Hemoglobin A1c May Be Useful Markers for Monitoring Changes in Intrahepatic Lipid Content in Japanese Patients With Overweight or Obesity and Type 2 Diabetes

Takemoto, A., Sada, Y., Oyanagi, T., Sasaki, Y., Sone, M., & Tanaka, Y. (2022) · Journal of Endocrinology and Metabolism · doi:10.14740/jem803

Non-obese non-alcoholic fatty liver disease is correlated with type 2 diabetes in Chinese adultsPreprint

Wei, X., Ding, X., Wang, X., Tang, M., Cao, H., Dong, W., Peng, Y., & Fan, N. (2022) · Research Square · doi:10.21203/rs.3.rs-1683982/v1

Neck circumference – a marker of insulin resistance in the normal-weight Polish

Pastusiak, K., Michałowska, J. M., Seraszek‐Jaros, A., & Bogdański, P. (2022) · Acta Scientiarum Polonorum Technologia Alimentaria · doi:10.17306/j.afs.1021

Doença hepática gordurosa não alcoólica (DHGNA) e síndrome dos ovários policísticos (SOP): associação do polimorfismo no gene da patatin-like phospholipase domain containing 3 (PNPLA3) e alterações endócrinas e metabólicas

Recuero, A. M. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2022.tde-19072022-163406

Modulación de la microbiota intestinal en el tratamiento de la enfermedad de hígado graso no alcohólico y síndrome metabólico. Estudio de un tratamiento experimental con quercetina y de la transferencia de microbiota a ratones libres de gérmenes = Intestinal microbiota modulation in the treatment of non-alcoholic fatty liver disease and metabolic syndrome. Study of an experimental treatment with quercetin and intestinal microbiota transfer to germ-free mice

Porras, D. (2021) · Buleria (Universidad de León) · doi:10.18002/10612/13641

MAFLD in Obesity with Deteriorating Glucose ControlPreprint

Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Schultz, A. (2022) · Research Square · doi:10.21203/rs.3.rs-2393464/v1

Advances in the Study of Exosomal miRNAs in Diabetes and Its Complications

Xiang, F., & Wu, H. (2022) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2022.1012001

Non-Alcoholic Fatty Liver in Obesity with Deteriorating Glucose ControlPreprint

Forst, T. M., Botz, I., Berse, M., Voswinkel, S., Strempler, M.-E., Baumann, S., & Schultz, A. (2023) · Research Square · doi:10.21203/rs.3.rs-2393464/v2

Hepatic Lipid Droplet-Associated Proteome Changes Distinguish Dietary-Induced Fatty Liver from Insulin Resistance in Male MicePreprint

Woerkom, A. V., Harney, D. J., Nagarajan, S. R., Hakeem-Sanni, M. F., Lin, J., Hooke, M., Pulpitel, T., Cooney, G., Larance, M., Saunders, D., et al. (2023) · bioRxiv · doi:10.1101/2023.03.09.531813

Non-alcoholic Fatty Liver Disease: Pathology, Disease Models and Therapies

Wu, Z. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v36i.5702

Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases

You, M., Ruan, C., Yang, Q., Hobkirk, J., & Gao, P. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1246912

Vitamin D Improves the Lipotoxicity of Liver Cells by Adjusting Epigenetic Characteristics of Genes

Hu, S., & Reyimu, A. (2023) · Hepatitis Monthly · doi:10.5812/hepatmon-133758

Insulin Resistance in Multiple Organs and SystemsPreprint

Andrade, L. J. D. O., de Oliveira, G. C. M., Bittencourt, A. M. V., & de Oliveira, L. M. (2023) · Research Square · doi:10.21203/rs.3.rs-3200007/v1

Pathophysiology and Risk Stratification in Cardiovascular Diseases and NAFLD

Gîrleanu, I., & Chiriac, S. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-33548-8_13

Editorial: Secreted proteins as novel biomarkers and therapeutic targets in NAFLD

Xiong, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1277101

Wide Metabonomics and Lipidomics of Type 2 Diabetes Mellitus Risk in Chinese Adult TwinsPreprint

Huang, N., Hong, X., Cao, W., Lv, J., Yu, C., Sun, D., Liao, C., Pang, Y., Hu, R., Pang, Z., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4618842

Suboptimal Thyroid Function and Elevated ALT in Children and Adolescents with Severe Obesity: A Single Tertiary Center Experience

Konidari, A., Leka-Emiri, S., Tzifi, F., Mihas, C. C., Evangelopoulou, A., Dikaiakou, E., Kafetzi, M. L., & Vlachopapadopoulou, E. A. (2023) · Archives of Pediatrics · doi:10.29011/2575825x.100297

Correlation of FLI fatty liver index with insulin resistance indices in patients with metabolic syndrome

Mitrović, M., Mišević, V., & Popović, L. (2023) · Medicinski podmladak · doi:10.5937/mp74-40416

Assessment of the Purity of IMM-H014 and Its Related Substances for the Treatment of Metabolic-Associated Fatty Liver Disease Using Quantitative Nuclear Magnetic Resonance Spectroscopy

Zhang, H., Zhu, H., Wu, S., Tang, H., Zhang, W., Gong, X., Wang, T., Wang, Y., & Yang, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417508

Correlation Study of Exosome miRNA-126 in Patients with Metabolic Related Fatty Liver Disease after Ischemic Stroke

韩, 雪. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141044

Additional file 1 of Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis

Dai, L., Yuan, W., Jiang, R., Zhan, Z., Zhang, L., Xu, X., Qian, Y., Yang, W., & Zhang, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25052285

NAFLD PATHOGENESIS AND CLINICAL ASSOCIATIONS WITH CARDIOVASCULAR DISEASES

Valaitienė, J. (2024) · Health Sciences · doi:10.35988/sm-hs.2024.129

Hepatic dysmetabolism in polycystic ovarian syndrome: impact of paraoxonase-1 modulation by butyrate

Areloegbe, S. E. J., Oyekanmi, O. A., Ajadi, I. O., Ajadi, M. B., Atuma, C. L., Aturamu, A., & Olaniyi, K. S. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03580-8

The correlation between Hepatic Controlled Attenuation Parameter (CAP) value and Insulin Resistance (IR) was stronger than that between Body Mass Index, Visceral Fat Area and IRPreprint

Li, Z., Liu, R., Gao, X., Hou, D., Leng, M., Zhang, Y., Du, M., Zhang, S., & Li, C. (2024) · Research Square · doi:10.21203/rs.3.rs-4505877/v1

Relationship between Sedentary Time and physical activity in patients with Non-Alcoholic Fatty Liver Disease

Zaman, M., Afzal, M. S., & Zaidi, Y. A. (2023) · Journal of Fatima Jinnah Medical University · doi:10.37018/jfjmu/nlua1221

Expression of signal recognition particle 14 in hepatocellular carcinoma and its relationship with disease progression and patient survival

Tian, H., Tang, D., Ma, M., & Fu, X. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0055

Mediated Factors Associated with Metabolic Health among Obese AdolescentsPreprint

Moran‐Lev, H., Sternfeld, R., Lazmi, R., Ohayon, R., Dudi, R., Brener, A., Zelber‐Sagi, S., Cohen, S., Lubetzky, R., & Gepner, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-4699208/v1

Nonlinear relationship between the triglyceride–glucose index and alanine aminotransferase in children with short stature

Zhao, Q., Li, Y., Zhang, M., & Ban, B. (2024) · Scientific Reports · doi:10.1038/s41598-024-71608-8

Predictive value of simplified insulin resistance assessment indicators for metabolic syndrome in middle-aged and elderly Chinese without established diabetesPreprint

Zhang, X., Li, X., Wang, G., Li, J., Mu, Y., Wang, L., & Wang, S. (2024) · Research Square · doi:10.21203/rs.3.rs-5195777/v1

Povara bolii ficatului steatozic

Darii, F., & Tagadiuc, O. (2024) · Akademos · doi:10.52673/18570461.24.2-73.09

The Impact of Circadian Rhythms and Obesity on Metabolic Dysfunction-Associated Steatotic Liver Disease: A Cross-Sectional Analysis of NHANES 2017-2020 DataPreprint

Tang, X., Wang, F., Gao, Y., Liu, Y., Zhao, S.-L., Lu, J. L., Qin, J., & Zhang, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5061164

Insulin resistance as a mediator in the association between nickel exposure and metabolic dysfunction-associated steatotic liver disease

Liu, Z., Zhang, L., Wu, Y., Tan, Z., Li, G., Li, Z., Zhan, L., & Dong, W. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01567-7

Rationale for choosing antihypertensive therapy in a patient with NAFLD and arterial hypertension

Насрединович, М. С., Мехтиева, О. А., & Михайловна, Б. О. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-229-9-86-95

Polydatin Could Ameliorate Type 2 Diabetes Mellitus-Induced Nonalcoholic Fatty Liver by Suppressing Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells/Nucleotide-Binding Domain, Leucine-Rich Repeat-Containing Receptor, Pyrin Domain-Containing 3 Inflammasome Axis Activation

Luo, J., Zhou, L., Xu, J., Liu, T., Qu, L., Fan, M., Sun, D., & Piao, C. (2025) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_1_25

The Serum γ-Glutamyltransferase Level Is Associated with the Development of Hypertension in Alcohol Infrequent Drinkers but Not in Frequent Drinkers

Mori, K., Tanaka, M., Sato, T., Akiyama, Y., Ohnishi, H., Hanawa, N., & Furuhashi, M. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5129-24

Effect of PNPLA3 (rs738409), UCP2 (rs660339), and HFE (rs1800562, rs1800730, rs1799945) Gene Polymorphism Markers on Metabolic Parameters in Patients with Nonalcoholic Fatty Liver Disease

Smirnova, O. V., Владимировна, Л. Д., & Каспаров, Э. В. (2025) · Russian Journal of Genetics · doi:10.1134/s1022795424701837

The relationship between tobacco and non-alcoholic fatty liver disease incidence: a systematic review and meta-analysis of observational studies

Jin, J., Zhang, Y., & Huang, Y. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1670932

Zhuyu pill mitigates NAFLD through activation of IL22/JAK1/STAT3 signaling pathway

Wang, T., Zhang, X., Shen, T., & Zhou, Z. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10622-0

Additional file 1 of The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease

盛国太, Lu, S., Xie, Q., Peng, N., Kuang, M., & Zou, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16780902

Additional file 1 of Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease

Min, Y., Wei, X., Wei, Z., Song, G., Zhao, X., & Lei, Y. (2024) · Figshare · doi:10.6084/m9.figshare.25953297

Additional file 1 of Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis

Yin, X., Li, M., Wang, Y., Zhao, G., Yang, T., Zhang, Y., Guo, J., Meng, T., Du, R., Li, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26635089

Additional file 4 of Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis

Yin, X., Li, M., Wang, Y., Zhao, G., Yang, T., Zhang, Y., Guo, J., Meng, T., Du, R., Li, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26635098

Additional file 1 of The correlation between hepatic controlled attenuation parameter (CAP) value and insulin resistance (IR) was stronger than that between body mass index, visceral fat area and IR

Li, Z., Liu, R., Gao, X., Hou, D., Leng, M., Zhang, Y., Du, M., Zhang, S., & Chunjun, L. I. (2024) · Figshare · doi:10.6084/m9.figshare.26746973

Additional file 3 of Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease

Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635386

Additional file 1 of Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease

Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635380

Additional file 2 of Machine learning-based integration identifies the ferroptosis hub genes in nonalcoholic steatohepatitis

Dai, L., Yuan, W., Jiang, R., Zhan, Z., Zhang, L., Xu, X., Qian, Y., Yang, W., & Zhang, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25052459

Additional file 1 of Correlation between the triglyceride-glucose index and the onset of atrial fibrillation in patients with non-alcoholic fatty liver disease

Zhang, Y., Wang, L., Qi, J., Yu, B., Zhao, J., Pang, L., Zhang, W., & Bin, L. (2024) · Figshare · doi:10.6084/m9.figshare.26588019

Additional file 2 of Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease

Wang, M., Chang, M., Shen, P., Wei, W., Li, H., & Shen, G. (2024) · Figshare · doi:10.6084/m9.figshare.26635383

Additional file 2 of Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis

Yin, X., Li, M., Wang, Y., Zhao, G., Yang, T., Zhang, Y., Guo, J., Meng, T., Du, R., Li, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26635092

Additional file 3 of Herbal medicine formula Huazhuo Tiaozhi granule ameliorates dyslipidaemia via regulating histone lactylation and miR-155-5p biogenesis

Yin, X., Li, M., Wang, Y., Zhao, G., Yang, T., Zhang, Y., Guo, J., Meng, T., Du, R., Li, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26635095

Recent understanding of crosstalk between muscle and different organs in regulating freshwater fish flesh quality under stress condition: A review

Wu, L., Zhang, L., Peng, L., Long, Y., Song, G., Benjakul, S., You, J., Liu, R., Huang, Q., Ma, H., et al. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743574

The mechanism of aerobic exercise in ameliorating glycolipid metabolic disorders in metabolic syndrome rats via the miR-27a-PPARγ pathway

Wu, P., Wang, Z., Li, K., Gao, Y., Yang, J., Wang, J., Shan, C., Guo, Q., Yang, H., Wang, J., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0341129

d-Threitol alleviates symptoms of diabetes in db/db mice by reducing hepatic ceramide levels

Li, Q., Xu, S., Li, T., Lin, C. S. K., & Cheng, H. (2026) · Journal of Functional Foods · doi:10.1016/j.jff.2026.107261

Impact de l'obésité sur la toxicologie des contaminants alimentaires : l'exemple de la Fumonisine B1

Dopavogui, L. (2022) · theses.fr (ABES) · doi:10.70675/8fcfcad7z134cz4df2zade9z155636aa8994

Potential antiobesity and antihepatic steatosis effects of a Capsosiphon fulvescens (maesaengi) ethanol extract: in vitro and in vivo studies

Lee, S. M., Park, S.-Y., & Kim, J. Y. (2026) · Food & Function · doi:10.1039/d5fo05258k

Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?

Carbinatti, T. (2024) · theses.fr (ABES) · doi:10.70675/5d147ab4zad37z4f6bzac51z32a08efeaa51

Effets de peptides interférents inhibant l’activité de la neuraminidase-1 sur l’activation du récepteur de l’insuline : approche cellulaire et intégrée

Toussaint, K. (2024) · theses.fr (ABES) · doi:10.70675/02ee4897z0b68z4c19zba0cz6cce7622b3d4

Shengdihuang Xiyangshen Zhimu Cangzhu Formula Improves Hepatic Glycogen Synthesis via the JNK/c‐Jun/IRS1/GSK3 β Signaling Pathway

Qu, K., Li, M., Sun, J., Wu, S., Liu, X., Liu, K., Wu, S., & Guo, X. (2026) · Journal of Diabetes Research · doi:10.1155/jdr/6019622

Network Toxicology Reveals the Mechanisms of the Plasticizer Metabolite MECPP in Metabolic Diseases

Qiu, J., Cheng, C., Jiang, B., Yang, D., & Peng, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083550

Association between triglyceride-glucose-frailty index and metabolic dysfunction-associated fatty liver disease: Mediation analysis involving obesity indicators in the NHANES

Ruan, S., Liu, S., Zhang, X., Zhang, J. Y., Chen, C., Lu, H., Zheng, K., Fang, S., & Chen, X. (2026) · Medicine · doi:10.1097/md.0000000000048269

Discovery of Active Compounds in Qigui Jiangzhi Formula for Metabolic Dysfunction‐Associated Steatotic Liver Disease by a Multidimensional Phenotypic Analysis

Xu, X., Zhou, F., Wu, Z., Zhou, Y., Zhang, Y.-Y., Xu, M., Xing, X., Li, P., Wang, G.-J., & Yang, H. (2026) · Phytochemical Analysis · doi:10.1002/pca.70075

The Correlation between the Triglyceride-Glucose Index and the Severity of Non-Alcoholic Fatty Liver Disease in Obese Patients

Li, T., & Pan, S. (2026) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2026.175011

Impact of liver and pancreatic steatosis on behavioral responses in rats under experimental conditions and after cessation of combined exposure to steatogenic factors

Halinska, A. M., Maltseva, O. A., & Halinskyi, O. O. (2026) · GASTROENTEROLOGY · doi:10.22141/2308-2097.60.2.2026.721

Multifunctional scaffold inspired by hepatocyte exosomes promotes bone regeneration by regulating osteogenic differentiation via PI3K/AKT pathway

Zhang, Y., He, J., Zeng, Y., Song, Y., Wang, Z., Wang, Q., You, Z., & Sun, J. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103360

Transcriptomic analysis reveals organ-specific adaptations in the gut-liver axis during diet domestication of mandarin fish (Siniperca chuatsi)

Li, H.-Y., Hou, Z.-G., Xu, Y., Wu, C., Qi, Z.-L., Gao, X.-W., Zhao, C., Zhao, X., & Zhang, L.-H. (2026) · Aquaculture International · doi:10.1007/s10499-026-02606-y

FGF21 and SHBG as Putative Hepatic Axes in Maternal Metabolic Adaptation: A Hypothetical Framework for Postpartum Insulin Sensitivity Restoration

Purc-Bandurko, K., Trojnar, K., Masiarz, A., Bandurko, A., Kimber-Trojnar, Ż., & Leszczyńska‐Gorzelak, B. (2026) · Biomolecules · doi:10.3390/biom16070998

Retinoic acid disrupts cumulus granulosa cells function via EGFR downregulation: induction of PCOS and infertility in adult female mice

Said, A., Marzouk, M., Mahmoud, A., Emad, M., Elkhbery, M., Alwutayd, K. M., Alkhateeb, M. A., Aldawsari, M. A., Elaziz, A. E. S. A., & AbdElkhalek, A. S. (2026) · Histochemistry and Cell Biology · doi:10.1007/s00418-026-02508-3

From local to systemic: Spinal aging in the multi-organ aging network

Zhang, C., 彭舒畅, Fu, J., Du, Y., Qian, Y., Song, Y., Wang, K. J., & Yang, C. G. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103253

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism

Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 57

Effect of the hepatic extracellular vesicles in inflammation-associated insulin resistance in non-alcoholic fatty liver disease

Alén, R., García‐Martinez, I., Izquierdo, M., & Valverde, Á. M. (2020) · Journal of Hepatology · doi:10.1016/s0168-8278(20)30717-0 · Cited by 1

Role of hepatokines in non-alcoholic fatty liver disease

Ke, Y., Xu, C., Lin, J., & Li, Y. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0029 · Cited by 46

Hepatokines: Linking nonalcoholic fatty liver disease and insulin resistance

Meex, R. C. R., & Watt, M. J. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.56 · Cited by 631

NAFLD and Insulin Resistance: A Multisystemic Disease

Gastaldelli, A. (2020) · Springer eBooks · doi:10.1007/978-3-319-95828-6_4 · Cited by 4